VRTX Vertex Pharmaceuticals
Nasdaq · SEC CIK 875320 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $158.38M 53 sales by 13 insiders
- Filings on record
- 531 since 2021-07-16, latest 2026-09-10 16:31
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| LEIDEN JEFFREY M | Executive COB, Dir | — | $60.94M |
| Sachdev Amit | EVP Chief Patient, Ext Af Off | — | $28.38M |
| Kewalramani Reshma | CEO, Pres, Dir | — | $19.74M |
| Bozic Carmen | EVP, CMO | — | $11.31M |
| WAGNER CHARLES F JR | EVP, CO, FO | — | $10.78M |
| Tatsis Ourania | EVP, Chief Reg, Quality Off | — | $6.51M |
| McKechnie Duncan | EVP, Chief Commercial Off | — | $5.66M |
| Biller Jonathan | EVP, CLO | — | $4.08M |
| Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | — | $3.60M |
| Bunnage Mark E. | EVP, CSO | — | $3.00M |
Transactions 621
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 16:31 | 2026-09-08 | VRTX | van Grunsven Jasper | EVP, CP, NPPO | A - Grant | $0.00 | +8,682 | 8,682 | New | $0 | |
| 2026-09-01 16:39 | 2026-08-28 | VRTX | Ambrose Kristen | SVP, CAO | A - Grant | $0.00 | +5,000 | 11.6K | +75% | $0 | |
| 2026-08-31 16:20 | 2026-08-27 | VRTX | SACHS BRUCE I | Dir | G - Gift | $0.00 | -6,000 | 39.0K | -13% | $0 | |
| 2026-07-23 16:15 | 2026-07-21 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | A - Grant | $0.00 | +8,251 | 53.6K | +18% | $0 | |
| 2026-07-23 16:13 | 2026-07-21 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | A - Grant | $0.00 | +8,251 | 66.5K | +14% | $0 | |
| T | 2026-07-07 16:15 | 2026-07-02 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | S - Sale | $524.99 | -1,500 | 45.3K | -3% | -$787.5K |
| T | 2026-07-07 16:08 | 2026-07-02 | VRTX | McKechnie Duncan | EVP, Chief Commercial Off | S - Sale | $519.00 | -1,541 | 11.0K | -12% | -$799.8K |
| T | 2026-07-06 16:13 | 2026-07-01 | VRTX | Liu Joy | EVP, CLO | S - Sale | $502.71 | -828 | 19.1K | -4% | -$416.2K |
| T | 2026-06-30 16:09 | 2026-06-26 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $482.50 | -596 | 15.3K | -4% | -$287.6K |
| T | 2026-06-23 16:08 | 2026-06-18 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $462.17 | -1,020 | 15.9K | -6% | -$471.4K |
| T | 2026-06-17 16:12 | 2026-06-15 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $450.00 | -4,062 | 17.0K | -19% | -$1.83M |
| T | 2026-06-09 16:24 | 2026-06-05 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $450.00 | -1,745 | 21.0K | -8% | -$785.2K |
| T | 2026-06-03 16:06 | 2026-06-01 | VRTX | Liu Joy | EVP, CLO | S - Sale | $439.91 | -828 | 20.0K | -4% | -$364.2K |
| T | 2026-06-02 16:04 | 2026-05-29 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $450.00 | -1,974 | 22.8K | -8% | -$888.3K |
| T | 2026-05-19 16:05 | 2026-05-15 | VRTX | Bunnage Mark E. | EVP, CSO | S - Sale | $453.45 | -33 | 7,284 | -0.5% | -$15.0K |
| T | 2026-05-19 16:04 | 2026-05-15 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $453.45 | -1,354 | 24.7K | -5% | -$614.0K |
| T | 2026-05-14 16:10 | 2026-05-12 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $450.00 | -6,988 | 26.1K | -21% | -$3.14M |
| D | 2026-05-05 17:44 | 2026-05-01 | VRTX | Upadhyay Suketu | Dir | D - Sale to Iss | — | -796 | 1,558 | -34% | — |
| D | 2026-05-05 17:37 | 2026-05-01 | VRTX | Thornberry Nancy | Dir | A - Grant | $0.00 | +472 | 2,507 | +23% | $0 |
| D | 2026-05-05 17:37 | 2026-05-01 | VRTX | Thornberry Nancy | Dir | D - Sale to Iss | — | -398 | 2,109 | -16% | — |
| D | 2026-05-05 17:29 | 2026-05-01 | VRTX | Schneider Jennifer | Dir | A - Grant | $0.00 | +472 | 2,190 | +27% | $0 |
| D | 2026-05-05 17:29 | 2026-05-01 | VRTX | Schneider Jennifer | Dir | D - Sale to Iss | — | -796 | 1,394 | -36% | — |
| D | 2026-05-05 17:18 | 2026-05-01 | VRTX | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +943 | 3,174 | +42% | $0 |
| D | 2026-05-05 17:18 | 2026-05-01 | VRTX | MCKENZIE DIANA | Dir | D - Sale to Iss | — | -796 | 2,378 | -25% | — |
| T | 2026-05-05 17:11 | 2026-05-01 | VRTX | Liu Joy | EVP, CLO | S - Sale | $425.02 | -1,104 | 20.7K | -5% | -$469.2K |
| D | 2026-05-05 16:58 | 2026-05-01 | VRTX | Garber Alan M | Dir | A - Grant | $0.00 | +472 | 7,344 | +7% | $0 |
| T | 2026-05-05 16:51 | 2026-05-01 | VRTX | Bhatia Sangeeta N. | Dir | A - Grant | $0.00 | +943 | 5,242 | +22% | $0 |
| T | 2026-05-05 16:51 | 2026-05-04 | VRTX | Bhatia Sangeeta N. | Dir | S - Sale | $423.73 | -318 | 4,924 | -6% | -$134.7K |
| T | 2026-04-03 16:53 | 2026-04-01 | VRTX | Liu Joy | EVP, CLO | S - Sale | $449.17 | -978 | 21.8K | -4% | -$439.3K |
| 2026-03-31 | 2026-03-27 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $450.95 | -2,329 | 33.1K | -7% | -$1.05M | |
| 2026-03-17 | 2026-03-13 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $481.79 | -2,329 | 35.4K | -6% | -$1.12M | |
| 2026-03-13 | 2026-03-11 | VRTX | McKechnie Duncan | EVP, Chief Commercial Off | S - Sale | $498.42 | -2,633 | 12.5K | -17% | -$1.31M | |
| 2026-03-06 | 2026-03-04 | VRTX | McKechnie Duncan | EVP, Chief Commercial Off | S - Sale | $475.30 | -2,437 | 15.1K | -14% | -$1.16M | |
| 2026-03-04 | 2026-03-02 | VRTX | Liu Joy | EVP, CLO | S - Sale | $495.96 | -892 | 22.8K | -4% | -$442.4K | |
| 2026-03-03 | 2026-02-27 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $480.31 | -2,329 | 37.7K | -6% | -$1.12M | |
| M | 2026-03-03 | 2026-02-27 | VRTX | Kewalramani Reshma | CEO, Pres, Dir | S - Sale | $493.47 | -40.0K | 106.0K | -27% | -$19.74M |
| 2026-03-02 | 2026-02-26 | VRTX | Ambrose Kristen | SVP, CAO | S - Sale | $483.36 | -357 | 6,624 | -5% | -$172.6K | |
| 2026-02-26 | 2026-02-24 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $485.11 | -1,518 | 57.4K | -3% | -$736.4K | |
| 2026-02-26 | 2026-02-25 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $486.35 | -1,846 | 55.6K | -3% | -$897.8K | |
| 2026-02-26 | 2026-02-24 | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $485.11 | -3,547 | 34.8K | -9% | -$1.72M | |
| 2026-02-26 | 2026-02-25 | VRTX | Ambrose Kristen | SVP, CAO | S - Sale | $486.35 | -223 | 6,981 | -3% | -$108.5K | |
| 2026-02-26 | 2026-02-24 | VRTX | Ambrose Kristen | SVP, CAO | F - Tax | $485.11 | -546 | 7,204 | -7% | -$264.9K | |
| M | 2026-02-26 | 2026-02-25 | VRTX | McKechnie Duncan | EVP, Chief Commercial Off | S - Sale | $487.65 | -4,910 | 20.0K | -20% | -$2.39M |
| 2026-02-26 | 2026-02-24 | VRTX | McKechnie Duncan | EVP, Chief Commercial Off | F - Tax | $485.11 | -873 | 22.5K | -4% | -$423.5K | |
| 2026-02-26 | 2026-02-24 | VRTX | WAGNER CHARLES F JR | EVP, CO, FO | F - Tax | $485.11 | -1,744 | 47.0K | -4% | -$846.0K | |
| 2026-02-26 | 2026-02-24 | VRTX | Bozic Carmen | EVP, CMO | F - Tax | $485.11 | -1,453 | 40.1K | -3% | -$704.9K | |
| 2026-02-26 | 2026-02-24 | VRTX | Bunnage Mark E. | EVP, CSO | F - Tax | $485.11 | -582 | 7,904 | -7% | -$282.3K | |
| 2026-02-26 | 2026-02-25 | VRTX | Bunnage Mark E. | EVP, CSO | S - Sale | $486.35 | -620 | 7,284 | -8% | -$301.5K | |
| 2026-02-26 | 2026-02-24 | VRTX | Kewalramani Reshma | CEO, Pres, Dir | F - Tax | $485.11 | -4,981 | 138.3K | -3% | -$2.42M | |
| 2026-02-26 | 2026-02-24 | VRTX | Biller Jonathan | EVP, CLO | F - Tax | $485.11 | -1,144 | 14.6K | -7% | -$555.0K | |
| 2026-02-26 | 2026-02-25 | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $486.35 | -945 | 13.7K | -6% | -$459.6K | |
| 2026-02-26 | 2026-02-25 | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $486.35 | -668 | 18.4K | -3% | -$324.9K | |
| 2026-02-26 | 2026-02-24 | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $485.11 | -1,627 | 19.1K | -8% | -$789.3K | |
| 2026-02-26 | 2026-02-25 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | S - Sale | $486.35 | -260 | 46.8K | -0.6% | -$126.5K | |
| 2026-02-26 | 2026-02-24 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | F - Tax | $485.11 | -1,627 | 47.0K | -3% | -$789.3K | |
| DM | 2026-02-23 | 2026-02-19 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale+OE | $468.83 | -58.6K | 63.2K | -48% | -$27.48M |
| DM | 2026-02-23 | 2026-02-19 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | M - OptEx | $172.06 | +48.5K | 117.5K | +70% | +$8.35M |
| M | 2026-02-19 | 2026-02-17+ | VRTX | Bunnage Mark E. | EVP, CSO | S - Sale | $484.31 | -3,619 | 9,668 | -27% | -$1.75M |
| 2026-02-19 | 2026-02-17 | VRTX | Bunnage Mark E. | EVP, CSO | F - Tax | $483.75 | -1,110 | 12.1K | -8% | -$537.0K | |
| 2026-02-19 | 2026-02-17 | VRTX | Bunnage Mark E. | EVP, CSO | A - Grant | $0.00 | +2,584 | 13.2K | +24% | $0 | |
| 2026-02-19 | 2026-02-18 | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $483.75 | -2,964 | 38.3K | -7% | -$1.43M | |
| 2026-02-19 | 2026-02-17 | VRTX | LEIDEN JEFFREY M | Executive COB, Dir | A - Grant | $0.00 | +8,269 | 41.3K | +25% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | Kewalramani Reshma | CEO, Pres, Dir | A - Grant | $0.00 | +16.3K | 149.8K | +12% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | Kewalramani Reshma | CEO, Pres, Dir | F - Tax | $483.75 | -6,554 | 143.3K | -4% | -$3.17M | |
| 2026-02-19 | 2026-02-17 | VRTX | McKechnie Duncan | EVP, Chief Commercial Off | F - Tax | $483.75 | -1,148 | 23.3K | -5% | -$555.3K | |
| 2026-02-19 | 2026-02-17 | VRTX | McKechnie Duncan | EVP, Chief Commercial Off | A - Grant | $0.00 | +4,962 | 24.5K | +25% | $0 | |
| M | 2026-02-19 | 2026-02-17+ | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | S - Sale | $483.52 | -977 | 49.0K | -2% | -$472.4K |
| 2026-02-19 | 2026-02-17 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | F - Tax | $483.75 | -2,294 | 49.6K | -4% | -$1.11M | |
| 2026-02-19 | 2026-02-17 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | A - Grant | $0.00 | +5,789 | 51.9K | +13% | $0 | |
| M | 2026-02-19 | 2026-02-17+ | VRTX | Ambrose Kristen | SVP, CAO | S - Sale | $484.87 | -2,195 | 8,388 | -21% | -$1.06M |
| 2026-02-19 | 2026-02-17 | VRTX | Ambrose Kristen | SVP, CAO | A - Grant | $0.00 | +1,809 | 10.5K | +21% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | Ambrose Kristen | SVP, CAO | F - Tax | $483.75 | -598 | 9,945 | -6% | -$289.3K | |
| M | 2026-02-19 | 2026-02-17+ | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $484.18 | -3,720 | 17.0K | -18% | -$1.80M |
| 2026-02-19 | 2026-02-17 | VRTX | Biller Jonathan | EVP, CLO | F - Tax | $483.75 | -1,505 | 19.5K | -7% | -$728.0K | |
| 2026-02-19 | 2026-02-17 | VRTX | Biller Jonathan | EVP, CLO | A - Grant | $0.00 | +4,135 | 21.0K | +25% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | Bozic Carmen | EVP, CMO | A - Grant | $0.00 | +5,375 | 43.4K | +14% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | Bozic Carmen | EVP, CMO | F - Tax | $483.75 | -1,912 | 41.5K | -4% | -$924.9K | |
| 2026-02-19 | 2026-02-17 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | A - Grant | $0.00 | +5,789 | 71.2K | +9% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $483.75 | -2,140 | 69.0K | -3% | -$1.04M | |
| 2026-02-19 | 2026-02-17 | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | A - Grant | $0.00 | +4,962 | 25.1K | +25% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $483.75 | -1,530 | 23.6K | -6% | -$740.1K | |
| M | 2026-02-19 | 2026-02-17+ | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $484.93 | -2,848 | 21.5K | -12% | -$1.38M |
| 2026-02-19 | 2026-02-17 | VRTX | WAGNER CHARLES F JR | EVP, CO, FO | A - Grant | $0.00 | +7,365 | 51.1K | +17% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | WAGNER CHARLES F JR | EVP, CO, FO | F - Tax | $483.75 | -2,294 | 48.8K | -4% | -$1.11M | |
| 2026-02-18 | 2026-02-13 | VRTX | Bhatia Sangeeta N. | Dir | S - Sale | $500.00 | -266 | 4,299 | -6% | -$133.0K | |
| 2026-02-18 | 2026-02-13 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | F - Tax | $487.76 | -3,804 | 47.6K | -7% | -$1.86M | |
| 2026-02-18 | 2026-02-13 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | S - Sale | $499.99 | -1,500 | 46.1K | -3% | -$750.0K | |
| 2026-02-18 | 2026-02-13 | VRTX | Biller Jonathan | EVP, CLO | F - Tax | $487.76 | -2,993 | 17.8K | -14% | -$1.46M | |
| 2026-02-18 | 2026-02-13 | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $499.00 | -988 | 16.8K | -6% | -$493.0K | |
| 2026-02-18 | 2026-02-13 | VRTX | Ambrose Kristen | SVP, CAO | F - Tax | $487.76 | -1,393 | 8,734 | -14% | -$679.4K | |
| 2026-02-18 | 2026-02-13 | VRTX | Kewalramani Reshma | CEO, Pres, Dir | F - Tax | $487.76 | -13.0K | 133.5K | -9% | -$6.36M | |
| 2026-02-18 | 2026-02-13 | VRTX | Bunnage Mark E. | EVP, CSO | F - Tax | $487.76 | -2,283 | 10.6K | -18% | -$1.11M | |
| 2026-02-18 | 2026-02-13 | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $487.76 | -1,903 | 20.1K | -9% | -$928.2K | |
| 2026-02-18 | 2026-02-13 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $487.76 | -3,548 | 65.4K | -5% | -$1.73M | |
| 2026-02-18 | 2026-02-13 | VRTX | McKechnie Duncan | EVP, Chief Commercial Off | F - Tax | $487.76 | -2,283 | 19.5K | -10% | -$1.11M | |
| 2026-02-18 | 2026-02-13 | VRTX | WAGNER CHARLES F JR | EVP, CO, FO | F - Tax | $487.76 | -4,565 | 43.7K | -9% | -$2.23M | |
| 2026-02-18 | 2026-02-13 | VRTX | Bozic Carmen | EVP, CMO | F - Tax | $487.76 | -3,804 | 38.1K | -9% | -$1.86M | |
| 2026-02-12 | 2026-02-10 | VRTX | Kewalramani Reshma | CEO, Pres, Dir | F - Tax | $468.41 | -8,297 | 146.5K | -5% | -$3.89M | |
| 2026-02-12 | 2026-02-10 | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $468.41 | -872 | 23.8K | -4% | -$408.5K | |
| 2026-02-12 | 2026-02-11 | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $460.43 | -1,751 | 22.0K | -7% | -$806.2K |
Purchase Sale Sale after option exercise All abbreviations